InvestorsObserver is giving Kura Oncology Inc (KURA) an Analyst Rating Rank of 68, meaning KURA is ranked higher by analysts than 68% of stocks. The average price target for KURA is $41.428 and analyst’s rate the stock as a Strong Buy
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With Kura Oncology Inc Stock Today?
Kura Oncology Inc (KURA) stock is trading at $26.94 as of 1:45 PM on Friday, Mar 19, a gain of $0.99, or 3.84% from the previous closing price of $25.94. The stock has traded between $25.51 and $27.10 so far today. Volume today is less active than usual. So far 476,392 shares have traded compared to average volume of 858,717 shares.